TY - JOUR
T1 - Incidence of malignancies in patients with IgG4-related disease
AU - Hirano, Kenji
AU - Tada, Minoru
AU - Sasahira, Naoki
AU - Isayama, Hiroyuki
AU - Mizuno, Suguru
AU - Takagi, Kaoru
AU - Watanabe, Takeo
AU - Saito, Tomotaka
AU - Kawahata, Shuhei
AU - Uchino, Rie
AU - Hamada, Tsuyoshi
AU - Miyabayashi, Koji
AU - Mohri, Dai
AU - Sasaki, Takashi
AU - Kogure, Hirofumi
AU - Yamamoto, Natsuyo
AU - Nakai, Yousuke
AU - Yoshida, Haruhiko
AU - Ito, Yukiko
AU - Akiyama, Dai
AU - Toda, Nobuo
AU - Arizumi, Toshihiko
AU - Yagioka, Hiroshi
AU - Takahara, Naminatsu
AU - Matsubara, Saburo
AU - Yashima, Yoko
AU - Koike, Kazuhiko
PY - 2014
Y1 - 2014
N2 - Objective It has been discussed whether IgG4-related disease (IgG4-RD), including autoimmune pancreatitis (AIP), is associated with malignancy; however, the issue has not been clarified. Methods We analyzed 113 patients with IgG4-RD in whom malignancy was not diagnosed at the time of IgG4-RD onset and the follow-up period was longer than six months. A total of 95 patients had AIP. The mean follow-up period was 73 months. The incidence of the observed malignancies was compared with the expected incidence in an age- and sex-matched general Japanese population based on the Vital Statistics of Japan. Results There were 15 malignancies (lung cancer in five patients, pancreatic cancer in two patients, gastric cancer in two patients, bile duct cancer in one patient, renal cancer in one patient, breast cancer in one patient, tongue cancer in one patient, malignant melanoma in one patient and acute myeloid leukemia in one patient) in 14 patients during the follow-up period. The calculated standardized incidence rate of the total malignancies was not significant, that is, 1.04 (95% CI 0.57-1.75). Conclusion The incidence of total malignancies in IgG4-RD patients is similar to that observed in the general population. At present, it is reasonable to conclude that IgG4-RD is not associated with an increased incidence of total malignancies.
AB - Objective It has been discussed whether IgG4-related disease (IgG4-RD), including autoimmune pancreatitis (AIP), is associated with malignancy; however, the issue has not been clarified. Methods We analyzed 113 patients with IgG4-RD in whom malignancy was not diagnosed at the time of IgG4-RD onset and the follow-up period was longer than six months. A total of 95 patients had AIP. The mean follow-up period was 73 months. The incidence of the observed malignancies was compared with the expected incidence in an age- and sex-matched general Japanese population based on the Vital Statistics of Japan. Results There were 15 malignancies (lung cancer in five patients, pancreatic cancer in two patients, gastric cancer in two patients, bile duct cancer in one patient, renal cancer in one patient, breast cancer in one patient, tongue cancer in one patient, malignant melanoma in one patient and acute myeloid leukemia in one patient) in 14 patients during the follow-up period. The calculated standardized incidence rate of the total malignancies was not significant, that is, 1.04 (95% CI 0.57-1.75). Conclusion The incidence of total malignancies in IgG4-RD patients is similar to that observed in the general population. At present, it is reasonable to conclude that IgG4-RD is not associated with an increased incidence of total malignancies.
KW - Autoimmune pancreatitis
KW - Diabetes mellitus
KW - IgG4-related disease
KW - Malignancy
UR - http://www.scopus.com/inward/record.url?scp=84893500206&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.53.1342
DO - 10.2169/internalmedicine.53.1342
M3 - 記事
C2 - 24492683
AN - SCOPUS:84893500206
SN - 0918-2918
VL - 53
SP - 171
EP - 176
JO - Internal Medicine
JF - Internal Medicine
IS - 3
ER -